CORDIS · 952398 · H2020
CEMBO Excellence in the research area of Combating and evaluation of mixed biofilms.
Coordinator: UNIVERZITA KOMENSKEHO V BRATISLAVE (SK)
CEMBO aims at developing Excellence in the Research Area of Combating and Evaluation of Mixed Biofilms. This will be achieved by twinning the Comenius University in Bratislava (CU), Faculty of Natural Sciences (FNS) with outstanding EU institutions with high expertise in the areas of anti-biofilm strategies and biofilm visualisation. The team from FNS CU has an established scientific reputation and has exploited its expertise in the development of novel future technologies. The goal of the CEMBO project is to provide CU the opportunity to learn from partners, strengthen the research potential…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €900k awarded to the consortium. The project runs over approximately 3 years from 2020-12-01 to 2023-11-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from SK
see all →- FunGlass — Centre for functional and surface-functionalized glasses739566 · H2020 · €15.0M
- LignoSilva — Upgrade of the Centre of Excellence LignoSilva101059552 · HORIZON · €14.7M
- lorAI — Low Resource Artificial Intelligence101136646 · HORIZON · €14.0M
- RURALITIES — Climate smart, ecosystem-enhancing and knowledge-based rural expertise and training centres101060876 · HORIZON · €4.4M
- SASPRO 2 — Slovak Academic and Scientific PROgramme for experienced researchers945478 · H2020 · €4.3M
- REDIRNET — Emergency Responder Data Interoperability Network607768 · FP7 · €3.5M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the CSA funding scheme.
- What is the EU contribution?
- The European Commission contributes €900k toward a total project budget of €900k.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-WIDESPREAD-2018-2020.
- Who coordinates the project?
- The project is coordinated by UNIVERZITA KOMENSKEHO V BRATISLAVE (SK).
- What is the project timeline?
- The project runs from 2020-12-01 to 2023-11-30 — approximately 3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 952398.